FibroGen CEO resigns; shares fall

Kyntra Bio

25/07/2023 13:00

** Drugmaker FibroGen's  FGEN.O  shares down 1.4% at $2.06
premarket
    ** Company says Enrique Conterno resigned as CEO due to
personal reasons
    ** Names Thane Wettig as interim CEO, effective July 23
    ** Conterno will serve as a special adviser to Wettig during
transition period
    ** FGEN shares down 87% YTD

 (Reporting by Rupali Chaudhary in Bengaluru)
 ((Rupali.chaudhary@thomsonreuters.com))